An Oxford-designed vaccine for Nipah virus has launched phase two trials, in a “major milestone” for efforts to curb the deadly pathogen and boost pandemic preparedness ... directly affected by the virus.
This move aims to establish an indigenous supply, moving away from current imports and scaling up production to a mandated minimum of 1 lakh doses per week ....